Cited by 38

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion

Carradori, Dario, Labrak, Yasmine, Miron, Véronique E., Saulnier, Patrick, Eyer, Joël, Préat, Véronique, des Rieux, Anne·2020·Biomaterials

Abstract

Neural stem cells (NSC) are located in restricted areas of the central nervous system where they self-renew or differentiate into neurons, astrocytes or oligodendrocytes. The stimulation of endogenous NSC differentiation is one of the most promising therapeutic approaches to restore neurological function in patients affected by neurodegenerative diseases. Endogenous NSC of the subventricular zone (SVZ) can be selectively targeted by lipid nanocapsules (LNC) coated with the peptide NFLTBS.40-63 (NFL-LNC) after intra-lateral ventricular injection in the brain. NFL-LNC can potentially deliver active compounds to SVZ-NSC and thus promote their differentiation to treat neurodegenerative diseases. The aim of this work was to induce endogenous NSC differentiation by specifically delivering retinoic acid (RA) to SVZ-NSC via NFL-LNC. RA was successfully encapsulated into NFL-LNC and RA-NFL-LNC were incubated with primary rat SVZ-NSC. In vitro, RA-NFL-LNC decreased the number of nestin + (NSC marker) cells and neurospheres compared to controls and increased the number of GalC + (oligodendrocytic marker) cells. Then, RA-NFL-LNC were injected in the right lateral ventricle of a lysolecithin-induced rat focal white matter lesion model to evaluate their impact on oligodendrocyte repopulation and remyelination. RA-NFL-LNC significantly increased the percentage of mature oligodendrocytes, stimulating oligodendrogenesis, nearly to the pre-lesion levels. Thus, RA-NFL-LNC represent a promising…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2019.119653

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 5 references

Research works printed but not linked: 56

  1. Vadakkan, 2016, Neurodegenerative disorders share common features of “loss of function” states of a proposed mechanism of nervous system functions, Biomed. Pharmacother., 83, 412, 10.1016/j.biopha.2016.06.042 · DOI
  2. Barnham, 2004, Neurodegenerative diseases and oxidative stress, Nat. Rev. Drug Discov., 3, 205, 10.1038/nrd1330 · DOI · Paper page
  3. Ettle, 2016, Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders?, Mol. Neurobiol., 53, 3046, 10.1007/s12035-015-9205-3 · DOI · Paper page
  4. Vishwakarma, 2014, Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: a review, J. Adv. Res., 5, 277, 10.1016/j.jare.2013.04.005 · DOI
  5. Murrell, 2013, Expansion of multipotent stem cells from the adult human brain, PLoS One, 8, e71334, 10.1371/journal.pone.0071334 · DOI
  6. Carradori, 2017, The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation, Biomaterials, 123, 77, 10.1016/j.biomaterials.2017.01.032 · DOI
  7. Herberts, 2011, Risk factors in the development of stem cell therapy, J. Transl. Med., 9, 29, 10.1186/1479-5876-9-29 · DOI
  8. Simonson, 2015, The safety of human pluripotent stem cells in clinical treatment, Ann. Med., 47, 370, 10.3109/07853890.2015.1051579 · DOI
  9. Bocquet, 2009, Neurofilaments bind tubulin and modulate its polymerization, J. Neurosci., 29, 11043, 10.1523/JNEUROSCI.1924-09.2009 · DOI
  10. Lépinoux-Chambaud, 2016, The neurofilament‐derived peptide NFL‐TBS. 40‐63 targets neural stem cells and affects their properties, Stem cells Transl. Med., 5, 901, 10.5966/sctm.2015-0221 · DOI
  11. Fressinaud, 2014, Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy, J. Neurosci. Res., 92, 243, 10.1002/jnr.23308 · DOI
  12. Berges, 2012, Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit, PLoS One, 7, e49436, 10.1371/journal.pone.0049436 · DOI
  13. Carradori, 2016, NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo, J. Control. Release, 238, 253, 10.1016/j.jconrel.2016.08.006 · DOI
  14. Huynh, 2009, Lipid nanocapsules: a new platform for nanomedicine, Int. J. Pharm., 379, 201, 10.1016/j.ijpharm.2009.04.026 · DOI
  15. Curtis, 2007, The effect of neurodegenerative diseases on the subventricular zone, Nat. Rev. Neurosci., 8, 712, 10.1038/nrn2216 · DOI
  16. Gonzalez-Perez, 2011, Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor, Brain Res. Rev., 67, 147, 10.1016/j.brainresrev.2011.01.001 · DOI
  17. Zhao, 2019, Combined use of bFGF/EGF and all-trans-retinoic acid cooperatively promotes neuronal differentiation and neurite outgrowth in neural stem cells, Neurosci. Lett., 690, 61, 10.1016/j.neulet.2018.10.002 · DOI
  18. Tan, 2015, Retinoic acid induced the differentiation of neural stem cells from embryonic spinal cord into functional neurons in vitro, Int. J. Clin. Exp. Pathol., 8, 8129
  19. Carradori, 2018, The origin of neural stem cells impacts their interactions with targeted-lipid nanocapsules: potential role of plasma membrane lipid composition and fluidity, J. Control. Release, 292, 248, 10.1016/j.jconrel.2018.11.005 · DOI
  20. Ito, 2014, Metabolic requirements for the maintenance of self-renewing stem cells, Nat. Rev. Mol. Cell Biol., 15, 243, 10.1038/nrm3772 · DOI · Paper page
  21. Maia, 2011, Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles, ACS Nano, 5, 97, 10.1021/nn101724r · DOI · Paper page
  22. Xie, 2015, The effect of simvastatin treatment on proliferation and differentiation of neural stem cells after traumatic brain injury, Brain Res., 1602, 1, 10.1016/j.brainres.2014.03.021 · DOI
  23. Lamprecht, 2002, New lipid nanocapsules exhibit sustained release properties for amiodarone, J. Control. Release, 84, 59, 10.1016/S0168-3659(02)00258-4 · DOI
  24. Peltier, 2006, Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules, Pharm. Res., 23, 1243, 10.1007/s11095-006-0022-2 · DOI
  25. Resnier, 2017, Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse, Pharmacol. Res., 126, 54, 10.1016/j.phrs.2017.01.031 · DOI
  26. Lim, 2002, Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid, Int. J. Pharm.Stem Cells Transl. Med., 243, 135
  27. Castro, 2007, Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne, J. Microencapsul., 24, 395, 10.1080/02652040701288519 · DOI
  28. Li, 2011, All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells, J. Control. Release, 149, 281, 10.1016/j.jconrel.2010.10.019 · DOI · Paper page
  29. Lepinoux-Chambaud, 2016, The neurofilament-derived peptide NFL-TBS.40-63 targets neural stem cells and affects their properties, Stem Cells Transl.Med., 5, 901, 10.5966/sctm.2015-0221 · DOI
  30. Pastrana, 2011, Eyes wide open: a critical review of sphere-formation as an assay for stem cells, Cell Stem Cell, 8, 486, 10.1016/j.stem.2011.04.007 · DOI
  31. Johansson, 1999, Identification of a neural stem cell in the adult mammalian central nervous system, Cell, 96, 25, 10.1016/S0092-8674(00)80956-3 · DOI
  32. De Angelis, 2018, Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells, Cell Death Dis., 9, 6, 10.1038/s41419-017-0028-1 · DOI
  33. Wang, 2008, Retinoic acid maintains self-renewal of murine embryonic stem cells via a feedback mechanism, Differ.; Res. Biol. Divers., 76, 931
  34. Hsieh, 2016, A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting beta-catenin/LEF-1 signaling, Sci. Rep., 6, 19156, 10.1038/srep19156 · DOI
  35. Capurso, 2010, Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells, Self Nonself, 1, 335, 10.4161/self.1.4.13946 · DOI
  36. Bianco, 2017, Rapid serum-free isolation of oligodendrocyte progenitor cells from adult rat spinal cord, Stem Cell Rev Rep, 13, 499, 10.1007/s12015-017-9742-4 · DOI
  37. Hattori, 2012, Effects of all-trans retinoic acid nanoparticles on corneal epithelial wound healing, Graefes Arch. Clin. Exp. Ophthalmol., 250, 557, 10.1007/s00417-011-1849-8 · DOI
  38. Pak, 2018, Combined therapy involving electroacupuncture and treadmill exercise attenuates demyelination in the corpus callosum by stimulating oligodendrogenesis in a rat model of neonatal hypoxia-ischemia, Exp. Neurol., 300, 222, 10.1016/j.expneurol.2017.11.014 · DOI
  39. Cullen, 2019, Low-intensity transcranial magnetic stimulation promotes the survival and maturation of newborn oligodendrocytes in the adult mouse brain, Glia, 67, 1462, 10.1002/glia.23620 · DOI
  40. Olmstead, 2018, Transcranial and pulsed focused ultrasound that activates brain can accelerate remyelination in a mouse model of multiple sclerosis, J. Ther. Ultrasound, 6, 11, 10.1186/s40349-018-0119-1 · DOI
  41. Li, 2017, Enhancing oligodendrocyte differentiation by transient transcription activation via DNA nanoparticle-mediated transfection, Acta Biomater., 54, 249, 10.1016/j.actbio.2017.03.032 · DOI
  42. Starossom, 2019, Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation, Nat. Commun., 10, 217, 10.1038/s41467-018-08140-7 · DOI
  43. Rittchen, 2015, Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF), Biomaterials, 56, 78, 10.1016/j.biomaterials.2015.03.044 · DOI
  44. Woodruff, 1999, Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study, Glia, 25, 216, 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L · DOI
  45. de Paula Faria, 2014, PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis, Mult. Scler., 20, 1443, 10.1177/1352458514526941 · DOI
  46. Roskams, 1998, Expression of neuron-specific beta-III tubulin during olfactory neurogenesis in the embryonic and adult rat, Neuroscience, 83, 191, 10.1016/S0306-4522(97)00344-8 · DOI
  47. Krencik, 2011, Specification of transplantable astroglial subtypes from human pluripotent stem cells, Nat. Biotechnol., 29, 528, 10.1038/nbt.1877 · DOI
  48. Godinho, 2013, Immunohistochemical, ultrastructural and functional analysis of axonal regeneration through peripheral nerve grafts containing Schwann cells expressing BDNF, CNTF or NT3, PLoS One, 8, e69987, 10.1371/journal.pone.0069987 · DOI
  49. Liedtke, 1996, GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination, Neuron, 17, 607, 10.1016/S0896-6273(00)80194-4 · DOI · Paper page
  50. Marei, 2018, Differentiation of human olfactory bulb-derived neural stem cells toward oligodendrocyte, J. Cell. Physiol., 233, 1321, 10.1002/jcp.26008 · DOI
  51. Lin, 2006, New mouse oligodendrocyte precursor (mOP) cells for studies on oligodendrocyte maturation and function, J. Neurosci. Methods, 157, 187, 10.1016/j.jneumeth.2006.04.014 · DOI
  52. Zhu, 2008, NG2 cells generate both oligodendrocytes and gray matter astrocytes, Development, 135, 145, 10.1242/dev.004895 · DOI
  53. Goldman, 2015, 142, 3983
  54. Kanakasabai, 2012, PPARgamma agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes, PLoS One, 7, e50500, 10.1371/journal.pone.0050500 · DOI
  55. Azim, 2012, Intraventricular injection of FGF-2 promotes generation of oligodendrocyte-lineage cells in the postnatal and adult forebrain, Glia, 60, 1977, 10.1002/glia.22413 · DOI
  56. Santos, 2012, Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain, ACS Nano, 6, 10463, 10.1021/nn304541h · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Carradori, D., Labrak, Y., Miron, V. E., Saulnier, P., Eyer, J., Préat, V., & des Rieux, A.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2020-02
Volume
230
Pages
119653
ISSN
0142-9612
Cited by
38
References
5
Language
en
Funders
  • Fonds De La Recherche Scientifique - FNRS
  • International Foundation for Research in Paraplegia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review